19th May 2014 12:25
LONDON (Alliance News) - A vital signs software developer spun out from the University of Oxford's Institute of Biomedical Engineering on Monday said IP Group PLC was one of the investors to commit to its latest funding round. In a statement, Oxehealth said it secured GBP2.0 million from IP Read More
